Please enable JavaScript to continue using this application.

Compare $CBUS vs $VTVT | Chartloom

Compare

$CBUS vs $VTVT

Cibus Inc · vTv Therapeutics Inc

CBUS

Cibus Inc

VTVT

vTv Therapeutics Inc

Compare $CBUS vs $VTVT

Comparing Cibus Inc and vTv Therapeutics Inc

CBUSCibus Inc

VTVTvTv Therapeutics Inc

CBUSCibus Inc

Market cap

$118M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.82x

Rev growth (TTM)

-10.3%

YTD performance

-17.6%

52W performance

5.4%

FCF yield

-39.2%

VTVTvTv Therapeutics Inc

Market cap

$123M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

216600.0%

YTD performance

-21.3%

52W performance

38.3%

FCF yield

-13.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CBUS

VTVT

Detailed metrics comparison

CBUS

Cibus Inc

VTVT

vTv Therapeutics Inc

Market Cap

CBUS$118M

VTVT$123M

Enterprise Value

CBUS$352M

VTVT$36M

Price

CBUS$1.55

VTVT$31.18

P/E Ratio

CBUSN/A

VTVTN/A

P/S Ratio

CBUS27.22x

VTVT3.33x

EV/Sales

CBUS81.04x

VTVT0.98x

EV/EBITDA

CBUS0.00x

VTVT0.00x

P/B Ratio

CBUS8.83x

VTVT1.53x

P/FCF Ratio

CBUSN/A

VTVTN/A

EV/FCF

CBUS-7.59x

VTVT-2.16x

PEG Ratio

CBUSN/A

VTVTN/A

Forward P/E (NTM)

CBUSN/A

VTVTN/A

Forward P/S (NTM)

CBUS12.82x

VTVTN/A

Revenue (TTM)

CBUS$4M

VTVT$37M

Revenue Growth (YoY)

CBUS-10.3%

VTVT216600.0%

Forward Rev Growth

CBUS139.3%

VTVT-97.3%

Gross Margin (TTM)

CBUS100.0%

VTVT0.0%

Operating Margin (TTM)

CBUS0.0%

VTVT63.1%

EBITDA Margin (TTM)

CBUS-1124.2%

VTVT-25.1%

Net Margin (TTM)

CBUS-2258.9%

VTVT-12.9%

FCF Margin (TTM)

CBUS-1067.5%

VTVT-45.5%

Net Income (TTM)

CBUS$-98M

VTVT$-5M

FCF (TTM)

CBUS$-46M

VTVT$-17M

EPS (TTM)

CBUS-$1.28

VTVT-$0.38

ROE (TTM)

CBUS-32060.0%

VTVT-627.0%

ROA (TTM)

CBUS-3086.0%

VTVT-506.0%

ROIC (TTM)

CBUS-3627.0%

VTVT-626.0%

Cash

CBUS$20M

VTVT$87M

Debt

CBUS$254M

VTVT$0

Net Cash/Debt

CBUS$-234M

VTVT$87M

Current Ratio (TTM)

CBUS1.62x

VTVT12.48x

Quick Ratio (TTM)

CBUS1.47x

VTVT12.42x

Debt/Equity (TTM)

CBUS17.19x

VTVT0.00x

Debt/Assets (TTM)

CBUS0.0%

VTVT0.0%

Interest Coverage (TTM)

CBUSN/A

VTVTN/A

Net Debt/EBITDA (TTM)

CBUS0.00x

VTVT0.00x

Beta

CBUS1.70

VTVT0.23

52W Performance

CBUS5.4%

VTVT38.3%

YTD Performance

CBUS-17.6%

VTVT-21.3%

% from 52W High

CBUS-63.0%

VTVT-29.1%

% from 52W Low

CBUS42.2%

VTVT59.9%

Asset Turnover (TTM)

CBUS0.01x

VTVT0.37x

FCF Yield (TTM)

CBUS-39.2%

VTVT-13.6%

Earnings Yield (TTM)

CBUS-83.0%

VTVT-3.9%

Dividend Yield (TTM)

CBUSN/A

VTVTN/A

Rule of 40

CBUS-1,077.8

VTVT216,554.5

EV/GP/RG

CBUS0.72

VTVTN/A

Ticker research

View CBUS research View VTVT research

Metric	CBUS Cibus Inc	VTVT vTv Therapeutics Inc
Market & Valuation
Market Cap	$118M	$123M
Enterprise Value	$352M	$36M
Price	$1.55	$31.18
P/E Ratio	N/A	N/A
P/S Ratio	27.22x	3.33x
EV/Sales	81.04x	0.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.83x	1.53x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.59x	-2.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.82x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$37M
Revenue Growth (YoY)	-10.3%	216600.0%
Forward Rev Growth	139.3%	-97.3%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	63.1%
EBITDA Margin (TTM)	-1124.2%	-25.1%
Net Margin (TTM)	-2258.9%	-12.9%
FCF Margin (TTM)	-1067.5%	-45.5%
Net Income (TTM)	$-98M	$-5M
FCF (TTM)	$-46M	$-17M
EPS (TTM)	-$1.28	-$0.38
ROE (TTM)	-32060.0%	-627.0%
ROA (TTM)	-3086.0%	-506.0%
ROIC (TTM)	-3627.0%	-626.0%
Financial Health
Cash	$20M	$87M
Debt	$254M	$0
Net Cash/Debt	$-234M	$87M
Current Ratio (TTM)	1.62x	12.48x
Quick Ratio (TTM)	1.47x	12.42x
Debt/Equity (TTM)	17.19x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.70	0.23
52W Performance	5.4%	38.3%
YTD Performance	-17.6%	-21.3%
% from 52W High	-63.0%	-29.1%
% from 52W Low	42.2%	59.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.37x
FCF Yield (TTM)	-39.2%	-13.6%
Earnings Yield (TTM)	-83.0%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,077.8	216,554.5
EV/GP/RG	0.72	N/A
Ticker research	View CBUS research	View VTVT research

Valuation

P/S Ratio

VTVT

3.33x

CBUS

27.22x

EV/FCF

CBUS

-7.59x

VTVT

-2.16x

Growth & revenue

Revenue Growth TTM

VTVT

216600.0%

CBUS

-10.3%

Forward Revenue Growth

CBUS

139.3%

VTVT

-97.3%

Profitability & performance

Gross Margin

CBUS

100.0%

VTVT

0.0%

ROE

VTVT

-627.0%

CBUS

-32060.0%

FCF Yield %

VTVT

-13.6%

CBUS

-39.2%

52-Week Performance

VTVT

38.3%

CBUS

5.4%

Detailed metrics comparison

CBUS

Cibus Inc

VTVT

vTv Therapeutics Inc

Market Cap

CBUS$118M

VTVT$123M

Enterprise Value

CBUS$352M

VTVT$36M

Price

CBUS$1.55

VTVT$31.18

P/E Ratio

CBUSN/A

VTVTN/A

P/S Ratio

CBUS27.22x

VTVT3.33x

EV/Sales

CBUS81.04x

VTVT0.98x

EV/EBITDA

CBUS0.00x

VTVT0.00x

P/B Ratio

CBUS8.83x

VTVT1.53x

P/FCF Ratio

CBUSN/A

VTVTN/A

EV/FCF

CBUS-7.59x

VTVT-2.16x

PEG Ratio

CBUSN/A

VTVTN/A

Forward P/E (NTM)

CBUSN/A

VTVTN/A

Forward P/S (NTM)

CBUS12.82x

VTVTN/A

Revenue (TTM)

CBUS$4M

VTVT$37M

Revenue Growth (YoY)

CBUS-10.3%

VTVT216600.0%

Forward Rev Growth

CBUS139.3%

VTVT-97.3%

Gross Margin (TTM)

CBUS100.0%

VTVT0.0%

Operating Margin (TTM)

CBUS0.0%

VTVT63.1%

EBITDA Margin (TTM)

CBUS-1124.2%

VTVT-25.1%

Net Margin (TTM)

CBUS-2258.9%

VTVT-12.9%

FCF Margin (TTM)

CBUS-1067.5%

VTVT-45.5%

Net Income (TTM)

CBUS$-98M

VTVT$-5M

FCF (TTM)

CBUS$-46M

VTVT$-17M

EPS (TTM)

CBUS-$1.28

VTVT-$0.38

ROE (TTM)

CBUS-32060.0%

VTVT-627.0%

ROA (TTM)

CBUS-3086.0%

VTVT-506.0%

ROIC (TTM)

CBUS-3627.0%

VTVT-626.0%

Cash

CBUS$20M

VTVT$87M

Debt

CBUS$254M

VTVT$0

Net Cash/Debt

CBUS$-234M

VTVT$87M

Current Ratio (TTM)

CBUS1.62x

VTVT12.48x

Quick Ratio (TTM)

CBUS1.47x

VTVT12.42x

Debt/Equity (TTM)

CBUS17.19x

VTVT0.00x

Debt/Assets (TTM)

CBUS0.0%

VTVT0.0%

Interest Coverage (TTM)

CBUSN/A

VTVTN/A

Net Debt/EBITDA (TTM)

CBUS0.00x

VTVT0.00x

Beta

CBUS1.70

VTVT0.23

52W Performance

CBUS5.4%

VTVT38.3%

YTD Performance

CBUS-17.6%

VTVT-21.3%

% from 52W High

CBUS-63.0%

VTVT-29.1%

% from 52W Low

CBUS42.2%

VTVT59.9%

Asset Turnover (TTM)

CBUS0.01x

VTVT0.37x

FCF Yield (TTM)

CBUS-39.2%

VTVT-13.6%

Earnings Yield (TTM)

CBUS-83.0%

VTVT-3.9%

Dividend Yield (TTM)

CBUSN/A

VTVTN/A

Rule of 40

CBUS-1,077.8

VTVT216,554.5

EV/GP/RG

CBUS0.72

VTVTN/A

Ticker research

View CBUS research View VTVT research

Metric	CBUS Cibus Inc	VTVT vTv Therapeutics Inc
Market & Valuation
Market Cap	$118M	$123M
Enterprise Value	$352M	$36M
Price	$1.55	$31.18
P/E Ratio	N/A	N/A
P/S Ratio	27.22x	3.33x
EV/Sales	81.04x	0.98x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.83x	1.53x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.59x	-2.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.82x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$37M
Revenue Growth (YoY)	-10.3%	216600.0%
Forward Rev Growth	139.3%	-97.3%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	63.1%
EBITDA Margin (TTM)	-1124.2%	-25.1%
Net Margin (TTM)	-2258.9%	-12.9%
FCF Margin (TTM)	-1067.5%	-45.5%
Net Income (TTM)	$-98M	$-5M
FCF (TTM)	$-46M	$-17M
EPS (TTM)	-$1.28	-$0.38
ROE (TTM)	-32060.0%	-627.0%
ROA (TTM)	-3086.0%	-506.0%
ROIC (TTM)	-3627.0%	-626.0%
Financial Health
Cash	$20M	$87M
Debt	$254M	$0
Net Cash/Debt	$-234M	$87M
Current Ratio (TTM)	1.62x	12.48x
Quick Ratio (TTM)	1.47x	12.42x
Debt/Equity (TTM)	17.19x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.70	0.23
52W Performance	5.4%	38.3%
YTD Performance	-17.6%	-21.3%
% from 52W High	-63.0%	-29.1%
% from 52W Low	42.2%	59.9%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.37x
FCF Yield (TTM)	-39.2%	-13.6%
Earnings Yield (TTM)	-83.0%	-3.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,077.8	216,554.5
EV/GP/RG	0.72	N/A
Ticker research	View CBUS research	View VTVT research